Pharmaceutical Exporter From India To Australia - Pharmaceutical companies and governmental entities typically import medicines from other nations, which are among Australia's main imports. In 2021, the country imported medications worth around 10.7 billion USD. Australia is one of the main attractions for doing business in trade with quality medicines since these are the products that are highly demanded due to less production scale within the nation.
With a big transformation in the pharma market of Australia, Cardiac Lifecare comes with quality medicines and represents itself as a leading Pharmaceutical Exporter From India To Australia. Working as per the norms set by WHO and GMP in order to maintain the professionalism and standard in the company as per the global standard. Moreover, our pharma exporting company has the main motive of making people disease free and also making them aware of the quality of medicines.
This is a prominent platform for importing pharma products to Australia since all our products are manufactured by utilizing cutting-edge technology. More than 350 pharma products are available at reasonable prices for exporting from India to other nations. And all are the most demanded products. That is why people with pharma companies in Australia prefer us to get special products like nephrology, cardiac, diabetic, neuro, and many others. Moreover, in order to make the services more beneficial, we provide them with the full assistance of importing as well as stock availability.
27
Years of Experience
3000
Associates
10000
Happy customers
12
Countries Served
400
Employees
Cardiac Lifecare has been working for the health of our society's members and has produced a variety of goods that are high in cardiac and diabetes medications. We not only operate in the country, but we also export enormous amounts of pharmaceutical items to foreign countries. Cardiac Lifecare represents a specialty in cardiac medications as well as diabetes and neuro drugs that making it the top Pharmaceutical Exporter From India To Australia. As a result, we are regarded as a leading pharma drug exporting firm in India for Australia.
The company has a cutting-edge production facility, which is the primary reason behind our high-quality products. The unit is built on a large plot of land with excellent infrastructure. It is divided into divisions for various operations such as raw material sorting, packing, production, logistics, and many more. That makes our entire process go more smoothly. In addition, below are some of our company's characteristics.
Our primary focus is ensuring the efficacy of our pharma products, which we achieve through stringent testing measures. Furthermore, our extensive selection of products offers unparalleled convenience to our clients as they can have all their needs met under one roof. This further solidifies our position as the top Cardiac Diabetic Medicine Company in India.
Cardiac Lifecare is revolutionizing the cardiac medicines market with its cutting-edge pharmaceutical products developed utilizing the latest innovations and technology. Our main objective is to make the society disease-free. In pursuit of this objective, our goals are;
Under the guidance of Shri Yogendra Somdutt Chopra, Lifecare Neuro was founded in 1994 with the aim to provide high-quality pharma medicines that could help people lead a happy, healthy life. As the top Cardiac Drugs Manufacturers in India, our mission is to develop quality formulations and make them easily accessible to people worldwide at the most affordable prices.
We comply with the stringent guidelines set by WHO-GMP, GLP, and FSSAI to ensure the best possible output, maintain proper hygiene, and systematize batches.
Our product packaging is meticulously designed and tested to ensure the integrity and durability of the medicines, even under the most challenging conditions, like extreme temperatures, continuous movements during transportation, etc.
Our manufacturing unit is situated in Baddi, Himachal Pradesh, which is an excise-free location. This helps to substantially trim down our overhead charges, allowing us to offer cost-effective pharma products without compromising on quality.
The Therapeutic Products Administration (TGA), Australia's drug regulatory authority, has agreed to expedite faster and easier approvals for India's generic pharmaceutical products that have already been approved by developed countries such as the United States, the United Kingdom, and the European Union, making it easier for Indian pharmaceutical companies to launch their products in the Australian market.
The Australian pharmaceuticals market was valued at USD 25,250 million in 2020 and is predicted to reach USD 28,750 million in 2026, growing at a 2.1 percent CAGR from 2021 to 2026. Most pharmaceutical and biotech firms have switched their emphasis to R&D departments in order to uncover novel compounds or leads for the treatment of this condition, which is currently in the final stages of clinical trials.
Product is the main focus of our company since all the pharma sector is running on the product as it is the main aspect of the complete sector before services. Cardiac Lifecare thinks that supplying high-quality pharmaceutical items is synonymous with producing substantial market returns. As a consequence, we placed a great value on maintaining product quality while still keeping costs low. To remain competitive in the industry, our Research & Development team performs research on novel chemicals and atoms and offers the most recent pharma goods to the market.
Moreover, in order to maintain quality, we process our goods in a robust supply chain management in which we are able to cope with minimizing raw materials where it is not required while manufacturing, as well as managing each activity to maintain quality and cost-effectiveness that makes us the leading pharma company that exports pharma drugs from India to Australia.
Importing pharmaceutical items requires adhering to stringent legal regulations established in the Pharmaceutical Products Act. In general, unless they are exempt from registration, things must be registered in the Australian Register of Therapeutic Goods (ARTG) before they may be legitimately imported into Australia. Every ARTG entry has a sponsor,' who is in charge of applying for and keeping the ARTG entry active. In rare cases, unapproved therapeutic goods that are not on the ARTG can be legitimately imported.
The Australian Border Force (ABF) is in charge of clearing imported goods through customs when they first arrive in Australia. All items arriving at the Australian Border Force must be declared unless an exception exists. Additional clearance requirements, such as biosecurity, food safety, and drug control, may also apply to your pharmaceutical items.
If you are unclear if a prohibited chemical is included in the product you are importing, you should:
Consult the Office of Drug Control for a list of restricted drugs that require a license and/or permit to import (link is external)
Before you import, check: